Sellas Life Sciences' (SLS) experimental cancer vaccine, galinpepimut-S, met the main goal in a phase 3 trial involving patients with acute myeloid leukemia, it said Tuesday.
Shares soared over 160%, with intraday trading volume of over 101.7 million against a daily average of almost 7 million.
TPG (TPG) is closing in on a take-private deal for BILL Holdings (BILL), with an agreement likely in the coming days, the Financial Times reported Tuesday.
BILL shares jumped 10% as intraday trading volume climbed to over 6.6 million from a daily average of roughly 1.7 million.
LuxExperience (LUXE) reported a narrower fiscal Q1 net loss Tuesday following a stronger-than-expected rise in net sales.
Shares rose 8% as intraday trading volume rose to more than 626,000 from a daily average of about 224,000.
Price: 19.75, Change: +12.28, Percent Change: +164.32
Comments